Cartherics and Catalent Broaden Commercial Licensing Agreement
Cartherics and Catalent Extend Scope of Existing Commercial Licensing Agreement Cartherics Pty Ltd, a clinical-stage biotechnology company focused on developing next-generation immune cell therapies for high-impact women’s health conditions, has…
CMS Assigns COVID-19–Specific HCPCS Codes for Fresenius Kabi’s Tyenne® (tocilizumab-aazg)
Fresenius Kabi Receives CMS Approval for COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg) Fresenius Kabi, a subsidiary of Fresenius and a global leader in essential medicines and medical technologies, has…
Join 1,000+ Professionals at the Emergency Medicine Conference 2026
Join over 1,000 emergency medicine professionals from across the globe at the Annual Conference 2026, taking place in Birmingham on 28–30 April, as we come together to shape the future of the specialty. With a…
Cosette Pharmaceuticals Expands Branded Portfolio with SYMPAZAN® and Other Asset Acquisition from Assertio
Cosette Pharmaceuticals Broadens Branded Portfolio with Acquisition of SYMPAZAN® and Additional Assets from Assertio Cosette Pharmaceuticals has announced the successful closing of a strategic acquisition that significantly expands its branded…
Assertio to Be Acquired by Garda Therapeutics in Strategic Deal
Assertio Enters Definitive Agreement for Acquisition by Garda Therapeutics Assertio Holdings Inc. has announced a transformative set of transactions that will significantly reshape the company’s structure and deliver immediate value…
TAE Life Sciences Reports Breakthrough BNCT Data Showing Durable Tumor Control and Systemic Immune Response
TAE Life Sciences Highlights Breakthrough BNCT Research Showing Sustained Tumor Control and Systemic Immune Effects TAE Life Sciences has announced the publication of new preclinical research in ACS Pharmacology &…
Pilatus Biosciences to Present Sex-Specific CD36 Antibody Data in Colorectal Cancer at AACR 2026
Pilatus Biosciences to Showcase New Data on Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 Pilatus Biosciences has announced that it will present new preclinical findings at…
Lincotek Names New Global General Manager for Medical Division
Lincotek Announces Appointment of New Global General Manager for Its Medical Division Lincotek has announced the appointment of Gianluca Fioravanti as Global General Manager of its Medical Division, marking a…
Virica Biotech and FUJIFILM Biosciences Partner to Advance AAV Production Enhancers Under Canada–Japan Program
Virica Biotech and FUJIFILM Biosciences Team Up to Advance AAV Production Enhancers Through Canada–Japan Co-Innovation Initiative Virica Biotech, a biotechnology firm focused on improving viral vector manufacturing through its proprietary…
Humana Inc. and CPESN USA Launch Value-Based Pharmacist Rewards Program to Enhance Chronic Care
Humana Inc. Healthy Horizons in Ohio and CPESN USA Introduce Value-Based Pharmacist Quality Rewards Program to Improve Chronic Disease Care Humana Inc., through its Medicaid plan Humana Healthy Horizons in…
Shionogi & Co., Ltd. Awarded U.S. Government Contract via BARDA Project BioShield for Drug-Resistant Bacterial Preparedness
Shionogi & Co., Ltd. Secures U.S. Government Contract via BARDA Project BioShield to Strengthen Preparedness Against Drug-Resistant Bacterial Threats Shionogi & Co., Ltd. has announced that its U.S.-based subsidiary, Shionogi…
Adagio Medical Receives U.S. Food and Drug Administration IDE Approval to Evaluate Next-Generation vCLAS® Ventricular Ablation System
Adagio Medical Secures U.S. Food and Drug Administration IDE Approval to Study Its Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio”), a medical technology company focused…